
Tobramycin and Dexamethasone Eye Drops
Bacterial Ocular Infection, Ocular Inflammation
0.1/0.3%
Tobramycin with dexamethasone 0.1/0.3% eye drops for bacterial ocular infection and ocular inflammation, an antibiotic and a steroid in one bottle.
Tobramycin is an aminoglycoside antibiotic commonly used as a topical treatment for bacterial ocular infections. It is available in various formulations including the brand Tobradex. Two tobramycin products are listed, both for eye conditions.

Bacterial Ocular Infection, Ocular Inflammation
0.1/0.3%
Tobramycin with dexamethasone 0.1/0.3% eye drops for bacterial ocular infection and ocular inflammation, an antibiotic and a steroid in one bottle.
Tobramycin is an antibiotic that stops the growth of susceptible bacteria. It is frequently formulated as eye drops or suspension to treat different issues within the Eye Care space. Because it is highly target-specific to the eye, it limits the need for systemic, whole-body administration.
This active ingredient targets bacterial threats to the eyes. It is commonly used for Bacterial Conjunctivitis and Blepharitis. When combined with agents like dexamethasone, it also addresses Ocular Inflammation alongside the active infection.
Tobramycin appears in both originator brands like Tobradex and generic preparations. These formulations come as eye drops or suspensions, allowing for direct application to the affected surface. Choosing between a pure Tobramycin product and a combination formulation depends on whether inflammation reduction is needed alongside antibacterial action.
Ensure you are not allergic to aminoglycoside antibiotics. Review your eye health history and current symptoms before application.
Common reactions include minor stinging or redness immediately after application. If visual disturbances or prolonged discomfort occur, discontinue use.
Use of multiple eye products simultaneously may reduce individual effectiveness. Individuals with existing ocular pressure issues or specific health conditions require careful attention when using ocular treatments.
Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.